Maggie Wallner

VP Clinical Development

Therapeutic Areas

Drug	Indication	Phase
Percutaneous Atrial Shunt Catheter System (PAS-C)	Symptomatic Heart Failure (with elevated left atrial pressure)	Pre-clinical